Patents by Inventor Karl KÖCHERT

Karl KÖCHERT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COPANLISIB BIOMARKERS
    Publication number: 20190382839
    Abstract: This invention provides biomarkers based on the gene expression profiling which can discriminate between patients who response to and/or with longer progression free survival and patients who do not response to and/or with shorter progression free survival from copanlisib treatment in lymphoma including indolent and aggressive NHLs and CLLs. The present invention relates to the use of genes from the BCR, PI3K, NFkB, IL6, inflammation and stromal processes as predictive biomarkers for various human cancers including but not limited to NHLs.
    Type: Application
    Filed: January 31, 2017
    Publication date: December 19, 2019
    Applicant: Bayer Pharma Aktiengesellschaft
    Inventors: Carol PENA, Li LIU, Jie CHENG, Karl KÖCHERT
  • COPANLISIB BIOMARKERS
    Publication number: 20190038632
    Abstract: This invention provides biomarkers based on the gene expression profiling which can discriminate between patients who response to and/or with longer progression free survival and patients who do not response to and/or with shorter progression free survival from copanlisib treatment in lymphoma including indolent and aggressive NHLs and CLLs. The present invention relates to the use of genes from the BCR, PI3K, NFkB, IL6, inflammation and stromal processes as predictive biomarkers for various human cancers including but not limited to NHLs.
    Type: Application
    Filed: January 30, 2017
    Publication date: February 7, 2019
    Applicant: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Li LIU, Carol PENA, Jie CHENG, Karl KÖCHERT